| Product Code: ETC7657617 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of in-vivo CRO services for oncology in Israel saw a significant shift in concentration levels from moderate to high in 2024. Germany, Switzerland, USA, China, and Hong Kong emerged as the top exporting countries to Israel in this sector. Despite a negative CAGR from 2020 to 2024, there was a notable growth rate of 8.69% from 2023 to 2024. This trend indicates a potential increase in demand for oncology-related in-vivo CRO services in Israel, with key players from major exporting countries playing a crucial role in meeting this demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Oncology Based In-vivo CRO Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Oncology Based In-vivo CRO Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Oncology Based In-vivo CRO Market - Industry Life Cycle |
3.4 Israel Oncology Based In-vivo CRO Market - Porter's Five Forces |
3.5 Israel Oncology Based In-vivo CRO Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Israel Oncology Based In-vivo CRO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing investments in oncology research and development |
4.2.3 Technological advancements in in-vivo testing for oncology treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for clinical trials in Israel |
4.3.2 High cost associated with oncology-based in-vivo CRO services |
4.3.3 Limited availability of skilled professionals in the field of oncology research |
5 Israel Oncology Based In-vivo CRO Market Trends |
6 Israel Oncology Based In-vivo CRO Market, By Types |
6.1 Israel Oncology Based In-vivo CRO Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Oncology Based In-vivo CRO Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Oncology Based In-vivo CRO Market Revenues & Volume, By Blood cancer, 2021- 2031F |
6.1.4 Israel Oncology Based In-vivo CRO Market Revenues & Volume, By Solid tumors, 2021- 2031F |
6.1.5 Israel Oncology Based In-vivo CRO Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Oncology Based In-vivo CRO Market Import-Export Trade Statistics |
7.1 Israel Oncology Based In-vivo CRO Market Export to Major Countries |
7.2 Israel Oncology Based In-vivo CRO Market Imports from Major Countries |
8 Israel Oncology Based In-vivo CRO Market Key Performance Indicators |
8.1 Average turnaround time for oncology-based in-vivo CRO services |
8.2 Number of successful clinical trials conducted in Israel |
8.3 Adoption rate of innovative in-vivo testing technologies in oncology research |
9 Israel Oncology Based In-vivo CRO Market - Opportunity Assessment |
9.1 Israel Oncology Based In-vivo CRO Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Israel Oncology Based In-vivo CRO Market - Competitive Landscape |
10.1 Israel Oncology Based In-vivo CRO Market Revenue Share, By Companies, 2024 |
10.2 Israel Oncology Based In-vivo CRO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |